Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
Edwin Bremer(University Medical Center Groningen), Wijnand Helfrich(University Medical Center Groningen)
Cited by 30
Related Papers
Superior Activity of Fusion Protein scFvRit:sFasL over Cotreatment with Rituximab and Fas Agonists
|Cancer Research|2008|46